NI
BOLD

Numeric Investors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Numeric Investors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.71M Buy
+86,600
New +$2.38M 0.02% 556

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Numeric Investors's BOLD Position: Q4 2017 in Review

Numeric Investors opened a new position in Audentes Therapeutics, Inc (BOLD) in Q4 2017: 86,600 shares worth $2.71M. The stake represents 0.02% of the portfolio and ranks #556 among its holdings.

89 funds tracked by Wall St. Rank hold BOLD as of Q4 2017.

  • Numeric Investors held 86,600 shares of Audentes Therapeutics, Inc worth $2.71M as of Q4 2017.
  • Audentes Therapeutics, Inc was a new Numeric Investors position in Q4 2017.
  • Audentes Therapeutics, Inc made up 0.02% of Numeric Investors's portfolio in Q4 2017, its #556 holding.
  • 89 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.